Selected research
Market Outlook & Growth Opportunities
Global Calming Aid for Dogs Market Outlook and Growth Opportunities 2026
Market perspective
The global Calming Aid for Dogs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Calming Aid for Dogs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Calming Aid for Dogs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Calming Aid for Dogs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Calming Aid for Dogs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Calming Aid for Dogs market include The Anxious Pet, This Dog's Life, NaturVet, King Kanine, Dr. Harvey’s, PetHonesty, Rescue Remedy, Zesty Paws and Maxxidog, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Calming Aid for Dogs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Calming Aid for Dogs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Calming Aid for Dogs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Calming Aid for Dogs market size, projected growth trends, production technologies, key applications, and end-use industries.
Calming Aid for Dogs Segment by Company
The Anxious Pet
This Dog's Life
NaturVet
King Kanine
Dr. Harvey’s
PetHonesty
Rescue Remedy
Zesty Paws
Maxxidog
Heavenly Hounds
ElleVet Sciences
Wild One
FOMO Bones
Ark Naturals
Purina
Kradle
Thunder
Finn
Pet Remedy
VetIQ
Zylkene
Adaptil
Primo Pup
Penelope's Bloom
Extract Labs
Koi CBD
Reggie
Zatural
Calming Aid for Dogs Segment by Type
Supplements
Pheromone Products
Prescription Medications
Others
Calming Aid for Dogs Segment by Application
Household
Commercial
Calming Aid for Dogs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Calming Aid for Dogs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Calming Aid for Dogs market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Calming Aid for Dogs significant trends, drivers, influence factors in global and regions.
6. To analyze Calming Aid for Dogs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Calming Aid for Dogs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Calming Aid for Dogs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Calming Aid for Dogs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Calming Aid for Dogs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Calming Aid for Dogs industry.
Chapter 3: Detailed analysis of Calming Aid for Dogs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Calming Aid for Dogs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Calming Aid for Dogs in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Supplements
- Pheromone Products
- Prescription Medications
- Others
Applications
- Household
- Commercial
Companies covered
- The Anxious Pet
- This Dog's Life
- NaturVet
- King Kanine
- Dr. Harvey’s
- PetHonesty
- Rescue Remedy
- Zesty Paws
- Maxxidog
- Heavenly Hounds
- ElleVet Sciences
- Wild One
- FOMO Bones
- Ark Naturals
- Purina
- Kradle
- Thunder
- Finn
- Pet Remedy
- VetIQ
- Zylkene
- Adaptil
- Primo Pup
- Penelope's Bloom
- Extract Labs
- Koi CBD
- Reggie
- Zatural
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Calming Aid for Dogs Sales Value (2021-2032)
- 1.2.2 Global Calming Aid for Dogs Sales Volume (2021-2032)
- 1.2.3 Global Calming Aid for Dogs Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Calming Aid for Dogs Market Dynamics
- 2.1 Calming Aid for Dogs Industry Trends
- 2.2 Calming Aid for Dogs Industry Drivers
- 2.3 Calming Aid for Dogs Industry Opportunities and Challenges
- 2.4 Calming Aid for Dogs Industry Restraints
3 Calming Aid for Dogs Market by Company
- 3.1 Global Calming Aid for Dogs Company Revenue Ranking in 2025
- 3.2 Global Calming Aid for Dogs Revenue by Company (2021-2026)
- 3.3 Global Calming Aid for Dogs Sales Volume by Company (2021-2026)
- 3.4 Global Calming Aid for Dogs Average Price by Company (2021-2026)
- 3.5 Global Calming Aid for Dogs Company Ranking (2024-2026)
- 3.6 Global Calming Aid for Dogs Company Manufacturing Base and Headquarters
- 3.7 Global Calming Aid for Dogs Company Product Type and Application
- 3.8 Global Calming Aid for Dogs Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Calming Aid for Dogs Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Calming Aid for Dogs Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Calming Aid for Dogs Market by Type
- 4.1 Calming Aid for Dogs Type Introduction
- 4.1.1 Supplements
- 4.1.2 Pheromone Products
- 4.1.3 Prescription Medications
- 4.1.4 Others
- 4.2 Global Calming Aid for Dogs Sales Volume by Type
- 4.2.1 Global Calming Aid for Dogs Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Calming Aid for Dogs Sales Volume by Type (2021-2032)
- 4.2.3 Global Calming Aid for Dogs Sales Volume Share by Type (2021-2032)
- 4.3 Global Calming Aid for Dogs Sales Value by Type
- 4.3.1 Global Calming Aid for Dogs Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Calming Aid for Dogs Sales Value by Type (2021-2032)
- 4.3.3 Global Calming Aid for Dogs Sales Value Share by Type (2021-2032)
5 Calming Aid for Dogs Market by Application
- 5.1 Calming Aid for Dogs Application Introduction
- 5.1.1 Household
- 5.1.2 Commercial
- 5.2 Global Calming Aid for Dogs Sales Volume by Application
- 5.2.1 Global Calming Aid for Dogs Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Calming Aid for Dogs Sales Volume by Application (2021-2032)
- 5.2.3 Global Calming Aid for Dogs Sales Volume Share by Application (2021-2032)
- 5.3 Global Calming Aid for Dogs Sales Value by Application
- 5.3.1 Global Calming Aid for Dogs Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Calming Aid for Dogs Sales Value by Application (2021-2032)
- 5.3.3 Global Calming Aid for Dogs Sales Value Share by Application (2021-2032)
6 Calming Aid for Dogs Regional Sales and Value Analysis
- 6.1 Global Calming Aid for Dogs Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Calming Aid for Dogs Sales by Region (2021-2032)
- 6.2.1 Global Calming Aid for Dogs Sales by Region: 2021-2026
- 6.2.2 Global Calming Aid for Dogs Sales by Region (2027-2032)
- 6.3 Global Calming Aid for Dogs Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Calming Aid for Dogs Sales Value by Region (2021-2032)
- 6.4.1 Global Calming Aid for Dogs Sales Value by Region: 2021-2026
- 6.4.2 Global Calming Aid for Dogs Sales Value by Region (2027-2032)
- 6.5 Global Calming Aid for Dogs Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Calming Aid for Dogs Sales Value (2021-2032)
- 6.6.2 North America Calming Aid for Dogs Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Calming Aid for Dogs Sales Value (2021-2032)
- 6.7.2 Europe Calming Aid for Dogs Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Calming Aid for Dogs Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Calming Aid for Dogs Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Calming Aid for Dogs Sales Value (2021-2032)
- 6.9.2 South America Calming Aid for Dogs Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Calming Aid for Dogs Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Calming Aid for Dogs Sales Value Share by Country, 2025 VS 2032
7 Calming Aid for Dogs Country-level Sales and Value Analysis
- 7.1 Global Calming Aid for Dogs Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Calming Aid for Dogs Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Calming Aid for Dogs Sales by Country (2021-2032)
- 7.3.1 Global Calming Aid for Dogs Sales by Country (2021-2026)
- 7.3.2 Global Calming Aid for Dogs Sales by Country (2027-2032)
- 7.4 Global Calming Aid for Dogs Sales Value by Country (2021-2032)
- 7.4.1 Global Calming Aid for Dogs Sales Value by Country (2021-2026)
- 7.4.2 Global Calming Aid for Dogs Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Calming Aid for Dogs Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Calming Aid for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Calming Aid for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Calming Aid for Dogs Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Calming Aid for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Calming Aid for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Calming Aid for Dogs Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Calming Aid for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Calming Aid for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Calming Aid for Dogs Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Calming Aid for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Calming Aid for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Calming Aid for Dogs Sales Value Growth Rate (2021-2032)
- 7.9.2 France Calming Aid for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Calming Aid for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Calming Aid for Dogs Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Calming Aid for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Calming Aid for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Calming Aid for Dogs Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Calming Aid for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Calming Aid for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Calming Aid for Dogs Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Calming Aid for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Calming Aid for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Calming Aid for Dogs Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Calming Aid for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Calming Aid for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Calming Aid for Dogs Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Calming Aid for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Calming Aid for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Calming Aid for Dogs Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Calming Aid for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Calming Aid for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Calming Aid for Dogs Sales Value Growth Rate (2021-2032)
- 7.16.2 China Calming Aid for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Calming Aid for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Calming Aid for Dogs Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Calming Aid for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Calming Aid for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Calming Aid for Dogs Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Calming Aid for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Calming Aid for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Calming Aid for Dogs Sales Value Growth Rate (2021-2032)
- 7.19.2 India Calming Aid for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Calming Aid for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Calming Aid for Dogs Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Calming Aid for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Calming Aid for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Calming Aid for Dogs Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Calming Aid for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Calming Aid for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Calming Aid for Dogs Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Calming Aid for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Calming Aid for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Calming Aid for Dogs Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Calming Aid for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Calming Aid for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Calming Aid for Dogs Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Calming Aid for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Calming Aid for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Calming Aid for Dogs Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Calming Aid for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Calming Aid for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Calming Aid for Dogs Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Calming Aid for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Calming Aid for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Calming Aid for Dogs Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Calming Aid for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Calming Aid for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Calming Aid for Dogs Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Calming Aid for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Calming Aid for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Calming Aid for Dogs Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Calming Aid for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Calming Aid for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Calming Aid for Dogs Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Calming Aid for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Calming Aid for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Calming Aid for Dogs Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Calming Aid for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Calming Aid for Dogs Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Calming Aid for Dogs Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Calming Aid for Dogs Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Calming Aid for Dogs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 The Anxious Pet
- 8.1.1 The Anxious Pet Company Information
- 8.1.2 The Anxious Pet Business Overview
- 8.1.3 The Anxious Pet Calming Aid for Dogs Sales, Value and Gross Margin (2021-2026)
- 8.1.4 The Anxious Pet Calming Aid for Dogs Product Portfolio
- 8.1.5 The Anxious Pet Recent Developments
- 8.2 This Dog's Life
- 8.2.1 This Dog's Life Company Information
- 8.2.2 This Dog's Life Business Overview
- 8.2.3 This Dog's Life Calming Aid for Dogs Sales, Value and Gross Margin (2021-2026)
- 8.2.4 This Dog's Life Calming Aid for Dogs Product Portfolio
- 8.2.5 This Dog's Life Recent Developments
- 8.3 NaturVet
- 8.3.1 NaturVet Company Information
- 8.3.2 NaturVet Business Overview
- 8.3.3 NaturVet Calming Aid for Dogs Sales, Value and Gross Margin (2021-2026)
- 8.3.4 NaturVet Calming Aid for Dogs Product Portfolio
- 8.3.5 NaturVet Recent Developments
- 8.4 King Kanine
- 8.4.1 King Kanine Company Information
- 8.4.2 King Kanine Business Overview
- 8.4.3 King Kanine Calming Aid for Dogs Sales, Value and Gross Margin (2021-2026)
- 8.4.4 King Kanine Calming Aid for Dogs Product Portfolio
- 8.4.5 King Kanine Recent Developments
- 8.5 Dr. Harvey’s
- 8.5.1 Dr. Harvey’s Company Information
- 8.5.2 Dr. Harvey’s Business Overview
- 8.5.3 Dr. Harvey’s Calming Aid for Dogs Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Dr. Harvey’s Calming Aid for Dogs Product Portfolio
- 8.5.5 Dr. Harvey’s Recent Developments
- 8.6 PetHonesty
- 8.6.1 PetHonesty Company Information
- 8.6.2 PetHonesty Business Overview
- 8.6.3 PetHonesty Calming Aid for Dogs Sales, Value and Gross Margin (2021-2026)
- 8.6.4 PetHonesty Calming Aid for Dogs Product Portfolio
- 8.6.5 PetHonesty Recent Developments
- 8.7 Rescue Remedy
- 8.7.1 Rescue Remedy Company Information
- 8.7.2 Rescue Remedy Business Overview
- 8.7.3 Rescue Remedy Calming Aid for Dogs Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Rescue Remedy Calming Aid for Dogs Product Portfolio
- 8.7.5 Rescue Remedy Recent Developments
- 8.8 Zesty Paws
- 8.8.1 Zesty Paws Company Information
- 8.8.2 Zesty Paws Business Overview
- 8.8.3 Zesty Paws Calming Aid for Dogs Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Zesty Paws Calming Aid for Dogs Product Portfolio
- 8.8.5 Zesty Paws Recent Developments
- 8.9 Maxxidog
- 8.9.1 Maxxidog Company Information
- 8.9.2 Maxxidog Business Overview
- 8.9.3 Maxxidog Calming Aid for Dogs Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Maxxidog Calming Aid for Dogs Product Portfolio
- 8.9.5 Maxxidog Recent Developments
- 8.10 Heavenly Hounds
- 8.10.1 Heavenly Hounds Company Information
- 8.10.2 Heavenly Hounds Business Overview
- 8.10.3 Heavenly Hounds Calming Aid for Dogs Sales, Value and Gross Margin (2021-2026)
- 8.10.4 Heavenly Hounds Calming Aid for Dogs Product Portfolio
- 8.10.5 Heavenly Hounds Recent Developments
- 8.11 ElleVet Sciences
- 8.11.1 ElleVet Sciences Company Information
- 8.11.2 ElleVet Sciences Business Overview
- 8.11.3 ElleVet Sciences Calming Aid for Dogs Sales, Value and Gross Margin (2021-2026)
- 8.11.4 ElleVet Sciences Calming Aid for Dogs Product Portfolio
- 8.11.5 ElleVet Sciences Recent Developments
- 8.12 Wild One
- 8.12.1 Wild One Company Information
- 8.12.2 Wild One Business Overview
- 8.12.3 Wild One Calming Aid for Dogs Sales, Value and Gross Margin (2021-2026)
- 8.12.4 Wild One Calming Aid for Dogs Product Portfolio
- 8.12.5 Wild One Recent Developments
- 8.13 FOMO Bones
- 8.13.1 FOMO Bones Company Information
- 8.13.2 FOMO Bones Business Overview
- 8.13.3 FOMO Bones Calming Aid for Dogs Sales, Value and Gross Margin (2021-2026)
- 8.13.4 FOMO Bones Calming Aid for Dogs Product Portfolio
- 8.13.5 FOMO Bones Recent Developments
- 8.14 Ark Naturals
- 8.14.1 Ark Naturals Company Information
- 8.14.2 Ark Naturals Business Overview
- 8.14.3 Ark Naturals Calming Aid for Dogs Sales, Value and Gross Margin (2021-2026)
- 8.14.4 Ark Naturals Calming Aid for Dogs Product Portfolio
- 8.14.5 Ark Naturals Recent Developments
- 8.15 Purina
- 8.15.1 Purina Company Information
- 8.15.2 Purina Business Overview
- 8.15.3 Purina Calming Aid for Dogs Sales, Value and Gross Margin (2021-2026)
- 8.15.4 Purina Calming Aid for Dogs Product Portfolio
- 8.15.5 Purina Recent Developments
- 8.16 Kradle
- 8.16.1 Kradle Company Information
- 8.16.2 Kradle Business Overview
- 8.16.3 Kradle Calming Aid for Dogs Sales, Value and Gross Margin (2021-2026)
- 8.16.4 Kradle Calming Aid for Dogs Product Portfolio
- 8.16.5 Kradle Recent Developments
- 8.17 Thunder
- 8.17.1 Thunder Company Information
- 8.17.2 Thunder Business Overview
- 8.17.3 Thunder Calming Aid for Dogs Sales, Value and Gross Margin (2021-2026)
- 8.17.4 Thunder Calming Aid for Dogs Product Portfolio
- 8.17.5 Thunder Recent Developments
- 8.18 Finn
- 8.18.1 Finn Company Information
- 8.18.2 Finn Business Overview
- 8.18.3 Finn Calming Aid for Dogs Sales, Value and Gross Margin (2021-2026)
- 8.18.4 Finn Calming Aid for Dogs Product Portfolio
- 8.18.5 Finn Recent Developments
- 8.19 Pet Remedy
- 8.19.1 Pet Remedy Company Information
- 8.19.2 Pet Remedy Business Overview
- 8.19.3 Pet Remedy Calming Aid for Dogs Sales, Value and Gross Margin (2021-2026)
- 8.19.4 Pet Remedy Calming Aid for Dogs Product Portfolio
- 8.19.5 Pet Remedy Recent Developments
- 8.20 VetIQ
- 8.20.1 VetIQ Company Information
- 8.20.2 VetIQ Business Overview
- 8.20.3 VetIQ Calming Aid for Dogs Sales, Value and Gross Margin (2021-2026)
- 8.20.4 VetIQ Calming Aid for Dogs Product Portfolio
- 8.20.5 VetIQ Recent Developments
- 8.21 Zylkene
- 8.21.1 Zylkene Company Information
- 8.21.2 Zylkene Business Overview
- 8.21.3 Zylkene Calming Aid for Dogs Sales, Value and Gross Margin (2021-2026)
- 8.21.4 Zylkene Calming Aid for Dogs Product Portfolio
- 8.21.5 Zylkene Recent Developments
- 8.22 Adaptil
- 8.22.1 Adaptil Company Information
- 8.22.2 Adaptil Business Overview
- 8.22.3 Adaptil Calming Aid for Dogs Sales, Value and Gross Margin (2021-2026)
- 8.22.4 Adaptil Calming Aid for Dogs Product Portfolio
- 8.22.5 Adaptil Recent Developments
- 8.23 Primo Pup
- 8.23.1 Primo Pup Company Information
- 8.23.2 Primo Pup Business Overview
- 8.23.3 Primo Pup Calming Aid for Dogs Sales, Value and Gross Margin (2021-2026)
- 8.23.4 Primo Pup Calming Aid for Dogs Product Portfolio
- 8.23.5 Primo Pup Recent Developments
- 8.24 Penelope's Bloom
- 8.24.1 Penelope's Bloom Company Information
- 8.24.2 Penelope's Bloom Business Overview
- 8.24.3 Penelope's Bloom Calming Aid for Dogs Sales, Value and Gross Margin (2021-2026)
- 8.24.4 Penelope's Bloom Calming Aid for Dogs Product Portfolio
- 8.24.5 Penelope's Bloom Recent Developments
- 8.25 Extract Labs
- 8.25.1 Extract Labs Company Information
- 8.25.2 Extract Labs Business Overview
- 8.25.3 Extract Labs Calming Aid for Dogs Sales, Value and Gross Margin (2021-2026)
- 8.25.4 Extract Labs Calming Aid for Dogs Product Portfolio
- 8.25.5 Extract Labs Recent Developments
- 8.26 Koi CBD
- 8.26.1 Koi CBD Company Information
- 8.26.2 Koi CBD Business Overview
- 8.26.3 Koi CBD Calming Aid for Dogs Sales, Value and Gross Margin (2021-2026)
- 8.26.4 Koi CBD Calming Aid for Dogs Product Portfolio
- 8.26.5 Koi CBD Recent Developments
- 8.27 Reggie
- 8.27.1 Reggie Company Information
- 8.27.2 Reggie Business Overview
- 8.27.3 Reggie Calming Aid for Dogs Sales, Value and Gross Margin (2021-2026)
- 8.27.4 Reggie Calming Aid for Dogs Product Portfolio
- 8.27.5 Reggie Recent Developments
- 8.28 Zatural
- 8.28.1 Zatural Company Information
- 8.28.2 Zatural Business Overview
- 8.28.3 Zatural Calming Aid for Dogs Sales, Value and Gross Margin (2021-2026)
- 8.28.4 Zatural Calming Aid for Dogs Product Portfolio
- 8.28.5 Zatural Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Calming Aid for Dogs Value Chain Analysis
- 9.1.1 Calming Aid for Dogs Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Calming Aid for Dogs Sales Mode & Process
- 9.2 Calming Aid for Dogs Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Calming Aid for Dogs Distributors
- 9.2.3 Calming Aid for Dogs Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst